1. Abramson, H. N., Banning, J. W., Nachtman, J. P., Roginski, E. T., Sardessai, M., Wormser, H. C., Wu, J., Nagia, Z., Schroeder, R. R., Bernardo, M. M., Synthesis of Anthraquinoyl Glucosaminosides and Studies on the Influence of Aglycone Hydroxyl Substitution on Superoxide Generation, DNA Binding, and Antimicrobial Propertiee.J. Med. Chem, 29(9), 1709–1714 (1986).
2. Andreani, A., Rambaldi, M., Bonazzi, D., Lelli, G., Greci, L., Potential antitumor agents, XIV., 8-Disubstituted anthraquinones.Arch. Pharm., 318, 842–848 (1985).
3. Baek, K. U., Song, G. Y., Kim, Y., Sok, D. E., and Ahn, B. Z., 2-(1-oxyalkyl)-1,4-dioxynaphthoquinone derivatives: Synthesis and evaluation of their antitumor activity.Arch. d. Pharmazie (Weinheim) 1997, in press.
4. Blanz, J., Mewes, K., Ehninger, G., Proksch, B., Waidelich, D., Greger, B., Zeller, K. P., Evidence for oxidative activation of mitoxantrone in human.Durg. Metab. Dispos., 19, 871–880 (1991).
5. Bodley, A., Liu, L. F., Israel, M., Seshadri, R., Koseki, Y., Giuliani, F. C., Kschenbaum, S., Silber, R., Potmesil, M., DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA.Cancer. Res., 49, 5969–5978 (1989).